Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol NDC 68180-848

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-848Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0848Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-848-13	68180084813	2 POUCH in 1 CARTON (68180-848-13) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACKMarketed from Dec 2, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: Lupin Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091674
Marketing start: Dec 2, 2011
Listing expires: Dec 31, 2026
Identifiers: Product ID 68180-848_f493571f-8402-4206-9dcb-3a227e60cc3cSPL ID f493571f-8402-4206-9dcb-3a227e60cc3cSPL set ID 7d82aa5d-aee9-4c72-9b9b-af7adad21f4cRxCUI 242297, 248310, 810096UPC 0368180848134, 0368180848110

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468180084813 followed by a unit qualifier and the quantity

Package 68180-0848-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets are a combination of levonorgestrel, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy.( 1 ) Levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets is indicated for use by females of reproductive potential to prevent pregnancy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)